Compass Pathways

Biotechnology

Director,PayerContracts

$215–305k ~AI est. New York, New York, United States; United States Remote Friendly
Market Sentiment
HIGH DEMAND

Neural analysis suggests this role is
optimal for Director candidates.

The Brief

“Director, Payer Contracts at Compass Pathways. Skills: Payer contracts, Contract strategy, Market access. Establish policies/procedures for contracting. Incorporate pricing/contracting strategies”

Industry & Context.

Biotechnology

What They're Looking For.

Must Have

Bachelor's degree required, 7+ years of work experience

Nice to Have

Master's degree preferred, Biopharmaceutical experience

What You'll Do.

Establish policies/procedures for contracting

Incorporate pricing/contracting strategies

Pressure test contract rationale

Ensure economic terms align with strategy

Provide input on pricing terms

Finalize business cases for contracts

Adhere to payer requirements

Support contract negotiations

Manage contract administration vendors

Monitor contract compliance

Contribute to pricing strategies

Understand legislative/policy impacts

Lead design of contracting programs

Partner with cross-functional teams

How You'll Work.

Team & Collaboration

Matrixed environment; Cross-functional teams; Market Access; Legal; Finance; Brand; Field Sales; Data Management; Government Affairs

Communication Scope

Influence executive decisions

Full Job Description

Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is headquartered in London, UK, with offices in New York City in the US. We focus on developing novel treatments that have the potential to improve the lives of those who are suffering with mental health conditions and who are not helped by current treatments.   We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP360 synthetic psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD) due to the pressing unmet need in this area. We are currently in phase 3 for TRD, have completed phase 2 studies for both post-traumatic stress disorder (PTSD) and anorexia nervosa and are planning a further late-stage study in PTSD. We envision a world where mental health means not just the absence of illness but the ability to thrive. - Compass Pathways. Job overview: The Director, Payer Contracts is responsible for the establishment, operationalization, and oversight of the entire lifecycle of commercial and government payer contracts to support the successful commercialization of COMP360. This role will play a critical part in developing contract strategy, guidelines, policies/procedures to ensure that our overall strategic direction is properly deployed. In addition, the Director of Payer contracts is responsible for the preparation/submission of bids, execution of contracts, and monitoring of payers’ ongoing compliance with terms and conditions. The Director of Payer Contracts will coordinate closely with matrix stakeholders to ensure that the trends affecting the needs of

Free ATS check

Applying for this Director, Payer Contracts role?

Most applicants get filtered before a human reads their resume. See if yours makes the cut.

How to Apply on Greenhouse

  • Create a Greenhouse profile before applying — it saves time across multiple applications.
  • Upload your resume as a PDF; the parser handles it better than Word.
  • Answer all knockout questions carefully — wrong answers auto-reject before a human sees you.
  • Enable email notifications to track application status in real time.

ANONYMOUS · UNFILTERED

What do employees actually say about Compass Pathways?

Real rants from real employees. Read before you apply.

Read Company Rants →